The company said it planned to seek Food and Drug Administration approval for the drug, orforglipron, before the end of the year.The company said it planned to seek Food and Drug Administration approval for the drug, orforglipron, before the end of the year. Eli Lilly and Company, GLP-1 RAs (Drug), Obesity, Weight, Research, Clinical Trials, Drugs (Pharmaceuticals) Read More
Pill Causes Major Weight Loss in Eli Lilly Trial’s Results
